We are live on ! Find out more
RBC

Roble Belko & Company Portfolio holdings

AUM $925M
1-Year Est. Return 19.7%
This Fund
S&P 500
This Quarter Est. Return
+2.59%
1 Year Est. Return
+19.7%
3 Year Est. Return
+53.27%
5 Year Est. Return
+47.85%
10 Year Est. Return
+149.75%
AUM
$181M
AUM Growth
+$3.99M
Cap. Flow
-$155K
Cap. Flow %
-0.09%
Top 10 Hldgs %
61.11%
Holding
320
New
48
Increased
38
Reduced
56
Closed
45

Sector Composition

Rank Sector Weight
1 Real Estate 3.09%
2 Financials 1.23%
3 Healthcare 1.05%
4 Technology 0.59%
5 Consumer Staples 0.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BOE icon
151
BlackRock Enhanced Global Dividend Trust
BOE
$676M
$22K 0.01%
1,820
DIS icon
152
Walt Disney
DIS
$170B
$21K 0.01%
214
PPG icon
153
PPG Industries
PPG
$25.3B
$21K 0.01%
+200
New +$21.8K
TEVA icon
154
Teva Pharmaceuticals
TEVA
$40.2B
$21K 0.01%
+425
New +$22.6K
DHR icon
155
Danaher
DHR
$139B
$20K 0.01%
298
+210
+239% +$13.7K
CNQ icon
156
Canadian Natural Resources
CNQ
$96.7B
$18K 0.01%
+1,225
New +$17.3K
PYPL icon
157
PayPal
PYPL
$49.5B
$18K 0.01%
+500
New +$19.1K
VOD icon
158
Vodafone
VOD
$36.1B
$18K 0.01%
586
-438
-43% -$14.2K
BGR icon
159
BlackRock Energy and Resources Trust
BGR
$416M
$17K 0.01%
1,200
-912
-43% -$12.5K
IYW icon
160
iShares US Technology ETF
IYW
$24.1B
$17K 0.01%
640
V icon
161
Visa
V
$683B
$17K 0.01%
227
-126
-36% -$9.87K
RDS.B
162
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$17K 0.01%
304
COL
163
DELISTED
Rockwell Collins
COL
$17K 0.01%
+200
New +$17.8K
AMZN icon
164
Amazon
AMZN
$3.06T
$16K 0.01%
440
-600
-58% -$20.3K
AZN icon
165
AstraZeneca
AZN
$245B
$16K 0.01%
260
SCHD icon
166
Schwab US Dividend Equity ETF
SCHD
$104B
$16K 0.01%
1,191
+1,005
+540% +$13.5K
TBPH icon
167
Theravance Biopharma
TBPH
$874M
$16K 0.01%
+714
New +$15.4K
AGN
168
DELISTED
Allergan plc
AGN
$16K 0.01%
+70
New +$16.1K
CLNY
169
DELISTED
Colony Capital, Inc.
CLNY
$16K 0.01%
1,065
-149,528
-99% -$2.6M
ABBV icon
170
AbbVie
ABBV
$433B
$15K 0.01%
243
CTSH icon
171
Cognizant
CTSH
$24.9B
$15K 0.01%
270
PG icon
172
Procter & Gamble
PG
$338B
$15K 0.01%
180
-193
-52% -$15.8K
AEP icon
173
American Electric Power
AEP
$69.9B
$14K 0.01%
200
BMY icon
174
Bristol-Myers Squibb
BMY
$134B
$14K 0.01%
190
-225
-54% -$15.9K
EMR icon
175
Emerson Electric
EMR
$86.7B
$14K 0.01%
260

Similar funds

Roble Belko & Company's Q2 2016 Portfolio in Review

As of Q2 2016, Roble Belko & Company held 320 positions worth $181M, up 2.3% from $177M the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Roble Belko & Company's Q2 2016 filing shows 48 new, 38 increased, 56 reduced and 45 closed positions. Its largest new stake was Vanguard Total International Stock ETF: 18,817 shares worth $837K. The largest sale was Colony Capital, Inc., an estimated $2.6M.

By sector, the portfolio is most concentrated in Real Estate at 3.1% of assets, up from 3% a quarter earlier, followed by Financials and Healthcare.

  • Roble Belko & Company's largest Q2 2016 buy was Vanguard Total International Stock ETF: 18,817 shares worth $837K.
  • Roble Belko & Company added most to Vanguard FTSE All-World ex-US ETF in Q2 2016, an estimated $764K increase.
  • Roble Belko & Company's biggest Q2 2016 reduction was Colony Capital, Inc., cutting an estimated $2.6M.
  • Roble Belko & Company fully exited Eaton Vance Tax-Managed Buy-Write Income Fund in Q2 2016, selling an estimated $102K.
  • Roble Belko & Company's ten largest holdings make up 61% of its $181M portfolio in Q2 2016.
  • Roble Belko & Company opened 48 new positions and closed 45 in Q2 2016.
  • Roble Belko & Company's portfolio value rose 2.3% quarter-over-quarter to $181M.

Based on Roble Belko & Company's 13F filing for Q2 2016, filed 11 Aug 2016.